Skip to content

Dogwood Therapeutics DWTX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$28.32M+17.3%-$34.26M+10.3%-$38.2M-54.4%-$24.74M-12.5%-$21.98M-78.0%
$40.37K+54.3%$26.15K+115%
$720.59K+103%$355.64K+22.0%$291.58K-13.6%$337.61K-19.9%$421.53K-11.4%
-$15.52M+0.6%-$15.62M+13.8%-$18.11M-15.0%-$15.75M-25.6%-$12.54M-42.6%
-$4.32M+48.2%-$8.33M-201%$8.22M-21.8%$10.52M-31.3%$15.3M+31.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Dogwood Therapeutics generate?
Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
Where does Dogwood Therapeutics's cash flow data come from?
Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.